Skip to main content
Guru Sonpavde, MD, Oncology, Orlando, FL

GuruPSonpavdeMD

Oncology Orlando, FL

Genitourinary Oncology

GU Oncology & Phase I Clinical Trial Director AdventHealth Cancer Institute Professor, University of Central Florida Orlando, FL, USA

Dr. Sonpavde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sonpavde's full profile

Already have an account?

  • Office

    2501 N Orange Ave
    Ste 689
    Orlando, FL 32804
    Phone+1 407-303-2024

Summary

  • Dr. Guru Sonpavde is an oncologist in Orlando, FL. He received his medical degree from Christian Medical College Vellore and has been in practice 27 years. He specializes in genitourinary oncology and is experienced in Phase I clinical trials and prostate cancer, urologic oncology, bladder cancer, kidney cancer and urinary tract cancer. He has more than ~500 publications.
  • Current and Emerging Agents to Treat Advanced Bladder Cancer

    Current and Emerging Agents to Treat Advanced Bladder Cancer

    A New Prognostic Model for Post-Platinum PD-L1 Inhibitors Treatment of Urothelia

    A New Prognostic Model for Post-Platinum PD-L1 Inhibitors Treatment of Urothelial Carcinoma

    Immunotherapy Outcomes in Pure vs Mixed Urothelial Carcinoma Histology

    Immunotherapy Outcomes in Pure vs Mixed Urothelial Carcinoma Histology

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
  • Nassau University Medical Center
    Nassau University Medical CenterResidency, Internal Medicine, 1992 - 1995
  • Christian Medical College Vellore
    Christian Medical College VelloreClass of 1990

Certifications & Licensure

  • CT State Medical License
    CT State Medical License Current
  • FL State Medical License
    FL State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2017 - 2024
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • RI State Medical License
    RI State Medical License 2020 - 2020
  • AL State Medical License
    AL State Medical License 2012 - 2017
  • TX State Medical License
    TX State Medical License 2003 - 2013
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer  
    G Sonpavde, C S Higano, T M Beer, Annals of Oncology
  • Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  
    Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
  • Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.  
    Sonpavde G, Pond GR, Fougeray R, Bellmunt J., BJU Int, 2014

Lectures

  • 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder ... 
    2019 ASCO Annual Meeting - 6/1/2019

Authored Content

  • Practice-changing and Practice-impacting Genitourinary Oncology Highlights From the ESMO Congress 2023October 2023
  • Genitourinary Oncology Highlights From the ASCO Annual Conference 2023June 2023
  • ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging AdvancesFebruary 2023
  • GU Updates Abound at ASCO 2021June 2021
  • Cancer treatment: is a clinical trial right for youMarch 2019
  • Immunotherapy for cancer therapy: What you need to knowJanuary 2019
  • Join now to see all

Press Mentions

  • Innovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth Physicians
    Innovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth PhysiciansJune 4th, 2024
  • Groundbreaking Ozempic Study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney Disease
    Groundbreaking Ozempic Study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney DiseaseMay 29th, 2024
  • New Approaches in the Bladder-Sparing Paradigm
    New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
  • Join now to see all

Professional Memberships